Evidence map›Paper›PMID 20518040›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2010

Acetal-modified dextran microparticles with controlled degradation kinetics and surface functionality for gene delivery in phagocytic and non-phagocytic cells.

Joel A Cohen, Tristan T Beaudette, Jessica L Cohen, Kyle E Broaders, Eric M Bachelder, Jean M J Fréchet

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Bioresponsive drug delivery systems for the treatment of inflammatory diseases.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nanoparticle-based technologies for retinal gene therapy.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2015
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Multimodal delivery of irinotecan from microparticles with two distinct compartments.Journal of controlled release : official journal of the Controlled Release Society · 2013
    Article
  18. Article
  19. Article
  20. Photoswitchable particles for on-demand degradation and triggered release.Small (Weinheim an der Bergstrasse, Germany) · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joel A CohenCollege of Chemistry, University of California, Berkeley, CA 94720-1460, USA.
Tristan T Beaudette
Jessica L Cohen
Kyle E Broaders
Eric M Bachelder
Jean M J Fréchet

Funding

SYNTHESIS COMPONENTU01HL080729 · NHLBI · WASHINGTON UNIVERSITY · PI WOOLEY, KAREN L. · 2005 to 2009
$12.1M
Nanoscale delivery vehicles for antigen-based vaccinesR01EB005824 · NIBIB · UNIVERSITY OF CALIFORNIA BERKELEY · PI FRECHET, JEAN M · 2005 to 2008
$2.0M
NHLBI NIH HHS 1 U01 HL080729-01NHLBI NIH HHS U01 HL080729NIBIB NIH HHS R01 EB005824
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

TransfectionAnimalsCell LineCell SurvivalDextransHeLa CellsHumansMacrophagesParticle SizePlasmidsPolymersSurface PropertiesDextransPolymers

Identifiers

PMID20518040
PMCPMC3379559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.